Biofrontera (BFRIW) Free Cash Flow (2020 - 2025)

Biofrontera's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$2.4 million for Q4 2025.

• In Q4 2025, Free Cash Flow fell 147.08% year-over-year to -$2.4 million; the TTM figure through Dec 2025 stood at -$13.4 million (down 30.37% YoY), while the FY2025 annual figure was -$13.4 million, down 30.37% from the prior year.
• Free Cash Flow was -$2.4 million for Q4 2025 at Biofrontera, up from -$3.8 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $94000.0 in Q2 2022 to a low of -$21.0 million in Q4 2021.
• Historically, Free Cash Flow has averaged -$4.6 million across 5 years, with a median of -$3.4 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow jumped 108.89% in 2022, then plunged 11084.04% in 2023.
• A 5-year view of Free Cash Flow shows it stood at -$21.0 million in 2021, then soared by 60.6% to -$8.3 million in 2022, then retreated by 7.12% to -$8.9 million in 2023, then surged by 88.98% to -$977000.0 in 2024, then sank by 147.08% to -$2.4 million in 2025.
• The last three Free Cash Flow figures came in at -$2.4 million (Q4 2025), -$3.8 million (Q3 2025), and -$3.1 million (Q2 2025), per Business Quant data.